{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:02:59Z","timestamp":1740139379463,"version":"3.37.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000085","name":"Ontario HIV Treatment Network","doi-asserted-by":"publisher","award":["EFP-1122-CBP"],"award-info":[{"award-number":["EFP-1122-CBP"]}],"id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hospital-based harm reduction services are needed to reduce drug-related harms, facilitate retention in care, and increase medical treatment adherence for people who use drugs. Philanthropic donor support plays a key role in delivering such innovative services which might fall outside current funding streams. However, little is known about how the principles, implementation, and practice of harm reduction services, which are often highly stigmatized, may impact donor behaviours. We explored this issue within Casey House, a speciality hospital in Toronto, Canada.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Our mixed methods study utilized an explanatory sequential design. A convenience sample of <jats:italic>n<\/jats:italic>\u2009=\u2009106 philanthropic individual donors, recruited via email, completed an anonymous web-based survey, between July and October 2020, which assessed their knowledge of harm reduction services and the potential impact of implementing new hospital-based harm reduction services on donors\u2019 future support. Following this, we conducted semi-structured qualitative interviews with <jats:italic>n<\/jats:italic>\u2009=\u200912 of the donors who completed a survey and volunteered to be interviewed. Interviews examined donors\u2019 perspectives about harm reduction and their hopes\/concerns for such programming at Casey House. Data were analysed using descriptive statistics and participatory-based thematic analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Survey data show a high level of support for hospital-based harm reduction services, with participants reporting that they \u201cstrongly agree\/agree\u201d with providing harm reduction equipment (85%), supervised consumption services (82%), and prescription opioid treatment (76%) at Casey House. A majority of participants (66%) claimed that implementing new harm reduction services at the hospital would not impact their future donation, while 6% said they would be less inclined to donate. Interview participants were supportive of harm reduction services at Casey House, recognizing the benefits of providing such services for hospital clients and the wider community. However, some spoke of the potential impact that implementing hospital-based harm reduction services may have on \u201cother\u201d donors who might be opposed. Although some believed harm reduction services should be fully funded by the government, most saw a role for donors in supporting such services.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings show support of hospital-based harm reduction services among philanthropic donors and provide insight into how donor support may be affected when such services are introduced.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00711-8","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:02:36Z","timestamp":1668639756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Philanthropic donor perspectives about providing harm reduction services for people living with HIV\/AIDS in a hospital setting"],"prefix":"10.1186","volume":"19","author":[{"given":"Katherine","family":"Rudzinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Chan Carusone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Ceranto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ib\u00e1\u00f1ez-Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Guta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Hyshka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra","family":"Cardow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Strike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"711_CR1","first-page":"24","volume":"36","author":"CO Erwin","year":"2013","unstructured":"Erwin CO. Classifying and comparing fundraising performance for nonprofit hospitals. J Health Hum Serv Adm. 2013;36:24\u201360.","journal-title":"J Health Hum Serv Adm"},{"key":"711_CR2","first-page":"96","volume":"60","author":"CO Erwin","year":"2015","unstructured":"Erwin CO. Organizational characteristics associated with fundraising performance of nonprofit hospitals. J Healthc Manag. 2015;60:96\u2013113.","journal-title":"J Healthc Manag"},{"key":"711_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1377\/hlthaff.25.2.541","volume":"25","author":"J Haderlein","year":"2006","unstructured":"Haderlein J. Unleashing the untapped potential of hospital philanthropy. Health Aff. 2006;25:541\u20135.","journal-title":"Health Aff"},{"key":"711_CR4","unstructured":"2018 annual development survey: executive summary. Washington DC: Association of American Medical Colleges; 2019. Available from: https:\/\/www.aamc.org\/system\/files\/2019-08\/2018-fundraising-data-executive-summary.pdf."},{"key":"711_CR5","unstructured":"Harm Reduction International. What is harm reduction? Available from: https:\/\/www.hri.global\/what-is-harm-reduction. Accessed 2 Dec 2021."},{"key":"711_CR6","unstructured":"Cook C, Bridge J, McLean S. The funding crisis for harm reduction. London: Harm Reduction International; 2014. Available from: https:\/\/www.hri.global\/files\/2014\/09\/22\/Funding_report_2014.pdf."},{"key":"711_CR7","unstructured":"Cook C, Davies C. The lost decade: neglect for harm reduction funding and the health crisis among people who use drugs. London: Harm Reduction International; 2018. Available from: https:\/\/www.hri.global\/files\/2018\/09\/25\/lost-decade-harm-reduction-funding-2018.PDF."},{"key":"711_CR8","unstructured":"Special Advisory Committee on the Epidemic of Opioid Overdoses. National report: opioid-related harms in Canada (Sep 2022). Ottawa: Public Health Agency of Canada (PHAC); 2021. Available from: https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids."},{"key":"711_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.0001","author":"J Stephenson","year":"2021","unstructured":"Stephenson J. CDC warns of surge in drug overdose deaths during COVID-19. JAMA Health Forum. 2021. https:\/\/doi.org\/10.1001\/jamahealthforum.2021.0001.","journal-title":"JAMA Health Forum"},{"key":"711_CR10","unstructured":"CDC. Provisional drug overdose death counts. Centre for Disease Control and Prevention. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm#data-tables. Accessed 20 Jan 2022."},{"key":"711_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2020.1318","author":"J Stephenson","year":"2020","unstructured":"Stephenson J. Drug overdose deaths head toward record number in 2020, CDC warns. JAMA Health Forum. 2020. https:\/\/doi.org\/10.1001\/jamahealthforum.2020.1318.","journal-title":"JAMA Health Forum"},{"key":"711_CR12","unstructured":"AMA. Issue brief: reports of increases in opioid-related overdose during COVID pandemic. American Medical Association; 2021. Available from: https:\/\/www.ama-assn.org\/system\/files\/2020-12\/issue-brief-increases-in-opioid-related-overdose.pdf."},{"key":"711_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1377\/hlthaff.2019.00705","volume":"39","author":"J Chubinski","year":"2020","unstructured":"Chubinski J, Lydenberg M. Philanthropic strategy in the face of an opioid epidemic. Health Aff. 2020;39:155\u201360.","journal-title":"Health Aff"},{"key":"711_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2014.01.010","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W, Wood E, Kerr T. Hospitals as a `risk environment: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. Soc Sci Med. 2014. https:\/\/doi.org\/10.1016\/j.socscimed.2014.01.010.","journal-title":"Soc Sci Med"},{"key":"711_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141594","author":"L Ti","year":"2015","unstructured":"Ti L, Milloy M, Buxton J, McNeil R, Dobrer S, Hayashi K, Wood E, Kerr T. Factors associated with leaving hospital against medical advice among people who use illicit drugs in Vancouver, Canada. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0141594.","journal-title":"PLoS ONE"},{"key":"711_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/dar.12270","volume":"34","author":"HK Grewal","year":"2015","unstructured":"Grewal HK, Ti L, Hayashi K, Dobrer S, Wood E, Kerr T. Illicit drug use in acute care settings. Drug Alcohol Rev. 2015;34:499\u2013502.","journal-title":"Drug Alcohol Rev"},{"key":"711_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa074","author":"EF Eaton","year":"2020","unstructured":"Eaton EF, Westfall AO, McClesky B, Paddock CS, Lane PS, Cropsey KL, Lee RA. In-hospital illicit drug use and patient-directed discharge: barriers to care for patients with injection-related infections. Open Forum Infect Dis. 2020. https:\/\/doi.org\/10.1093\/ofid\/ofaa074.","journal-title":"Open Forum Infect Dis"},{"key":"711_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","volume":"92","author":"LC Fannuchi","year":"2018","unstructured":"Fannuchi LC, Lofwall MR, Nuzzo PA, Walsh SL. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs. J Subst Abuse Treat. 2018;92:64\u20139.","journal-title":"J Subst Abuse Treat"},{"key":"711_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-1507-z","author":"K Rudzinski","year":"2021","unstructured":"Rudzinski K, Xavier J, Guta A, Chan Carusone S, King K, Phillips J, Switzer S, O\u2019Leary B, Baltzer Turje R, Harrison S, de Prinse K, Simons J, Strike C. Feasibility, acceptability, concerns, and challenges of implementing supervised injection services at a speciality HIV hospital in Toronto, Canada: perspectives of people living with HIV. BMC Public Health. 2021. https:\/\/doi.org\/10.1186\/s12889-021-1507-z.","journal-title":"BMC Public Health"},{"key":"711_CR20","doi-asserted-by":"publisher","first-page":"18855","DOI":"10.7448\/IAS.17.1.18855","volume":"17","author":"R McNeil","year":"2014","unstructured":"McNeil R, Dilley L, Guirguis-Younger M, Hwang S, Small W. Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV\/AIDS: a qualitative study. J Int AIDS Soc. 2014;17:18855.","journal-title":"J Int AIDS Soc"},{"key":"711_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/add.13214","volume":"111","author":"R McNeil","year":"2016","unstructured":"McNeil R, Kerr T, Pauly B, Wood E, Small W. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals. Addiction. 2016;111:685\u201394.","journal-title":"Addiction"},{"key":"711_CR22","doi-asserted-by":"publisher","first-page":"107523","DOI":"10.1016\/j.drugalcdep.2019.06.025","volume":"204","author":"E Hyshka","year":"2019","unstructured":"Hyshka E, Morris H, Anderson-Baron J, Nixon L, Dong K, Salvalaggio G. Patient perspectives on a harm reduction-oriented addiction medicine consultation team implemented in a large acute care hospital. Drug Alcohol Depend. 2019;204:107523.","journal-title":"Drug Alcohol Depend"},{"key":"711_CR23","doi-asserted-by":"publisher","first-page":"E476","DOI":"10.1503\/cmaj.191365","volume":"192","author":"KA Dong","year":"2020","unstructured":"Dong KA, Brouwer J, Johnston C, Hyshka E. Supervised consumption services for acute care hospital patients. CMAJ. 2020;192:E476\u20139.","journal-title":"CMAJ"},{"key":"711_CR24","unstructured":"Lasby D, Barr C. 30 years of giving in Canada\u2014the giving behaviour of Canadians: who gives, how, and why? Ottawa: Rideau Hall Foundation and Imagine Canada; 2018. Available from: https:\/\/imaginecanada.ca\/sites\/default\/files\/2019-05\/30years_report_en.pdf."},{"key":"711_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0899764012467084","volume":"42","author":"MHD van Leeuwen","year":"2012","unstructured":"van Leeuwen MHD, Wiepking P. National campaigns for charitable causes. Nonprofit Volunt Sect Q. 2012;42:219\u201340.","journal-title":"Nonprofit Volunt Sect Q"},{"key":"711_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0899764010380927","volume":"40","author":"R Bekkers","year":"2011","unstructured":"Bekkers R, Wiepking P. A literature review of empirical studies of philanthropy. Nonprofit Volunt Sect Q. 2011;40:924\u201373.","journal-title":"Nonprofit Volunt Sect Q"},{"key":"711_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-015-0022-5","author":"M Kulesza","year":"2015","unstructured":"Kulesza M, Teachman BA, Werntz AJ, Gasser ML, Lindgren KP. Correlates of public support toward federal funding for harm reduction strategies. Subst Abuse Treat Prev Policy. 2015. https:\/\/doi.org\/10.1186\/s13011-015-0022-5.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"711_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/nvsm.1547","volume":"21","author":"A Body","year":"2016","unstructured":"Body A, Breeze B. What are \u2018unpopular causes\u2019 and how can they achieve fundraising success? Int J Nonprofit Volunt Sect Market. 2016;21:57\u201370.","journal-title":"Int J Nonprofit Volunt Sect Market"},{"key":"711_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1332\/204080513X667792","volume":"4","author":"B Breeze","year":"2013","unstructured":"Breeze B. How donors choose charities: the role of personal taste and experiences in giving decisions. Volunt Sect Rev. 2013;4:165\u201383.","journal-title":"Volunt Sect Rev"},{"key":"711_CR30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1086\/677226","volume":"41","author":"S Lee","year":"2014","unstructured":"Lee S, Winterich KP, Ross WT. I\u2019m moral, but I won\u2019t help you: the distinct roles of empathy and justice in donations. J Consum Res. 2014;41:678\u201396.","journal-title":"J Consum Res"},{"key":"711_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/0899764002238096","volume":"31","author":"H Lune","year":"2016","unstructured":"Lune H. Weathering the storm: nonprofit organization survival strategies in a hostile climate. Nonprofit Volunt Sect Q. 2016;31:463\u201383.","journal-title":"Nonprofit Volunt Sect Q"},{"key":"711_CR32","first-page":"111","volume":"36","author":"A Benoit","year":"2014","unstructured":"Benoit A. \u2018From our lips:\u2019 lipstick as consumer technology and the MAC VIVA GLAM advertising campaigns. Sci Can. 2014;36:111\u201332.","journal-title":"Sci Can"},{"key":"711_CR33","unstructured":"Golub O. The Elton John AIDS Foundation. Borden Magazine. 2019. Available from: https:\/\/www.borgenmagazine.com\/the-elton-john-aids-foundation\/. Accessed 20 Jan 2022."},{"key":"711_CR34","unstructured":"CAMH. Today campaign: improving addiction treatment\u2014today we\u2019re changing the way we see and treat addiction. Centre for Addiction and Mental Health. Available from: https:\/\/www.camh.ca\/en\/today-campaign\/areas-of-impact\/improving-addiction-treatment. Accessed 20 Jan 2022."},{"key":"711_CR35","unstructured":"NAMI. NAMI walks your way: a new day for mental health. The National Alliance on Mental Illness. Available from: https:\/\/www.namiwalks.org\/ Accessed 20 Jan 2022."},{"key":"711_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM199408183310707","volume":"331","author":"P O'Connor","year":"1994","unstructured":"O\u2019Connor P, Selwyn P, Schottenfeld R. Medical care for injection drug users with human immunodeficiency virus infection. NEJM. 1994;331:450\u20136.","journal-title":"NEJM"},{"key":"711_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.idc.2007.03.009","volume":"21","author":"RD Bruce","year":"2007","unstructured":"Bruce RD, Altice FL. Clinical care of the HIV-infected drug user. Infect Dis Clin N Am. 2007;21:329\u201355.","journal-title":"Infect Dis Clin N Am"},{"key":"711_CR38","unstructured":"UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Geneva: Joint United Nations Programme on HIV\/AIDS; 2014. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en.pdf."},{"key":"711_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-017-0084-y","author":"C Simeone","year":"2017","unstructured":"Simeone C, Shapiro B, Lum PJ. Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic. Addict Sci Clin Pract. 2017. https:\/\/doi.org\/10.1186\/s13722-017-0084-y.","journal-title":"Addict Sci Clin Pract"},{"key":"711_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz009","author":"T Antoniou","year":"2019","unstructured":"Antoniou T, Graves E, Plumptre L, Stewart A, Chan Carusone S. Antiretroviral prescription pick-up and physician follow-up after hospital discharge among medically complex people with HIV. Open Forum Infect Dis. 2019. https:\/\/doi.org\/10.1093\/ofid\/ofz009.","journal-title":"Open Forum Infect Dis"},{"key":"711_CR41","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2105\/AJPH.2018.304600","volume":"108","author":"M Miskovic","year":"2018","unstructured":"Miskovic M, Chan Carusone S, Guta A, O\u2019Leary B, de Prinse K, Strike C. Distribution of harm reduction kits in a specialty HIV hospital. Am J Public Health. 2018;108:1363\u20135.","journal-title":"Am J Public Health"},{"key":"711_CR42","unstructured":"Liang J, Ryckman K, Corson L. Trends in paramedic-attended opioid overdoses: a review of suspected opioid overdoses in Toronto paramedic services data, 2017\/18. Toronto: Toronto Public Health; 2018. Available from: https:\/\/www.toronto.ca\/wp-content\/uploads\/2018\/11\/8f75-TrendsSuspectedOpioidOverdosesWeb.pdf."},{"key":"711_CR43","unstructured":"Minister of Justice Canada. Controlled Drugs and Substances Act. Ottawa: 2022. Available from: https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-38.8\/."},{"key":"711_CR44","first-page":"2009","volume-title":"Research design: qualitative, quantitative, and mixed-methods approaches","author":"J Creswell","year":"2009","unstructured":"Creswell J. Research design: qualitative, quantitative, and mixed-methods approaches. Los Angeles: Sage; 2009. p. 2009."},{"key":"711_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/2059799117703118","author":"E Moseholm","year":"2017","unstructured":"Moseholm E, Fetters MD. Conceptual models to guide integration during analysis in convergent mixed methods studies. Methodol Innov. 2017. https:\/\/doi.org\/10.1177\/2059799117703118.","journal-title":"Methodol Innov"},{"key":"711_CR46","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X05282260","author":"N Ivankova","year":"2006","unstructured":"Ivankova N, Creswell JW, Stick S. Using mixed-methods sequential explanatory design: from theory to practice. Field Methods. 2006. https:\/\/doi.org\/10.1177\/1525822X05282260.","journal-title":"Field Methods"},{"key":"711_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/heapro\/dat093","volume":"30","author":"S Flicker","year":"2014","unstructured":"Flicker S, Nixon S. The DEPICT model for participatory qualitative health promotion research analysis piloted in Canada, Zambia and South Africa. Health Promot Int. 2014;30:616\u201324.","journal-title":"Health Promot Int"},{"key":"711_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthplace.2019.102247","author":"S Switzer","year":"2020","unstructured":"Switzer S, Flicker S, McClelland A, Chan Carusone S, Ferguson TB, Herelle N, Yee D, Guta A, Strike C. Journeying together: a visual exploration of \u201cengagement\u201d as a journey in HIV programming and service delivery. Health Place. 2020. https:\/\/doi.org\/10.1016\/j.healthplace.2019.102247.","journal-title":"Health Place"},{"key":"711_CR49","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2105\/AJPH.2014.302522","volume":"105","author":"S Flicker","year":"2015","unstructured":"Flicker S, O\u2019Campo P, Monchalin R, Thistle J, Worthington C, Masching R, Guta A, Pooyak S, Whitebird W, Thomas C. Research done in \u201ca good way\u201d: the importance of Indigenous elder involvement in HIV community-based research. Am J Public Health. 2015;105:1149\u201354.","journal-title":"Am J Public Health"},{"key":"711_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59\u201382.","journal-title":"Field Methods"},{"key":"711_CR51","first-page":"875","volume-title":"The SAGE Encyclopedia of qualitative research methods","author":"M Sandelowski","year":"2008","unstructured":"Sandelowski M. Theoretical Saturation. In: Given L, editor. The SAGE Encyclopedia of qualitative research methods, vol. 2. Thousand Oaks: Sage; 2008. p. 875\u20136."},{"key":"711_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13643-020-01448-w","volume":"9","author":"C Greenhalgh","year":"2020","unstructured":"Greenhalgh C, Montgomery P. A systematic review of the barriers to and facilitators of the use of evidence by philanthropists when determining which charities (including health charities or programmes) to fund. Syst Rev. 2020;9:199.","journal-title":"Syst Rev"},{"key":"711_CR53","unstructured":"Fidelity Charitable. Overcoming barriers to giving. Boston: Fidelity Charitable; 2017. Available from: https:\/\/www.fidelitycharitable.org\/content\/dam\/fc-public\/docs\/insights\/overcoming-barriers-to-giving.pdf."},{"key":"711_CR54","unstructured":"Breeze B. How donors choose charities: findings of a study of donor perceptions of the nature and distribution of charitable benefit. London: ALLIANCE Publishing; 2010. Available from: http:\/\/www.cgap.org.uk\/uploads\/reports\/HowDonorsChooseCharities.pdf."},{"key":"711_CR55","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/1467-6494.00043","volume":"66","author":"RF Baumeister","year":"1998","unstructured":"Baumeister RF, Dale K, Sommer KL. Freudian defense mechanisms and empirical findings in modern social psychology: reaction formation, projection, displacement, undoing, isolation, sublimation, and denial. J Pers. 1998;66:1081\u2013124.","journal-title":"J Pers"},{"key":"711_CR56","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1037\/0022-3514.72.5.980","volume":"72","author":"LS Newman","year":"1997","unstructured":"Newman LS, Duff KJ. A new look at defensive projection: thought suppression, accessibility, and biased person perception. J Pers Soc Psychol. 1997;72:980\u20131001.","journal-title":"J Pers Soc Psychol"},{"key":"711_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/00797308.1970.11823276","volume":"25","author":"J Novick","year":"1970","unstructured":"Novick J, Kelly K. Projection and externalization. Psychoanal Study Child. 1970;25:69\u201395.","journal-title":"Psychoanal Study Child"},{"key":"711_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00428-6","author":"M Miovsky","year":"2020","unstructured":"Miovsky M, Miklikova S, Mravcik V, Grund JP, Cernikova T. Understanding the crisis in harm reduction funding in Central and Eastern Europe. Harm Reduct J. 2020. https:\/\/doi.org\/10.1186\/s12954-020-00428-6.","journal-title":"Harm Reduct J"},{"key":"711_CR59","unstructured":"Serebryakova L, Cook C, Davies C. Failure to fund: the continued crisis for harm reduction funding in low- and middle-income countries. . London: International HR; 2021. Available from: https:\/\/www.hri.global\/files\/2021\/08\/09\/HRI-FAILURE-TO-FUND-REPORT-LOWRES.PDF."},{"key":"711_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/dar.12337","volume":"35","author":"J Chalmers","year":"2016","unstructured":"Chalmers J, Ritter A, Berends L, Lancaster K. Following the money: mapping the sources and funding flows of alcohol and other drug treatment in Australia. Drug Alcohol Rev. 2016;35:255\u201362.","journal-title":"Drug Alcohol Rev"},{"key":"711_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0178-6","author":"DC Des Jarlais","year":"2017","unstructured":"Des Jarlais DC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J. 2017. https:\/\/doi.org\/10.1186\/s12954-017-0178-6.","journal-title":"Harm Reduct J"},{"key":"711_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0177-7","author":"E Hyshka","year":"2017","unstructured":"Hyshka E, Anderson-Baron J, Karekezi K, Belle-Isle L, Elliott R, Pauly B, Strike C, Asbridge M, Dell C, McBride K, Hathaway A, Wild TC. Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks. Harm Reduct J. 2017. https:\/\/doi.org\/10.1186\/s12954-017-0177-7.","journal-title":"Harm Reduct J"},{"key":"711_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2010.03.007","volume":"22","author":"C Strike","year":"2011","unstructured":"Strike C, Watson TM, Lavigne P, Hopkins S, Shore R, Young D, Leonard L, Millson P. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). Int J Drug Policy. 2011;22:34\u201340.","journal-title":"Int J Drug Policy"},{"key":"711_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugpo.2007.11.006","volume":"19","author":"AD Hathaway","year":"2008","unstructured":"Hathaway AD, Tousaw KI. Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver. Int J Drug Policy. 2008;19:11\u20136.","journal-title":"Int J Drug Policy"},{"key":"711_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.02.005","author":"C Strike","year":"2019","unstructured":"Strike C, Watson T. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. Int J Drug Policy. 2019. https:\/\/doi.org\/10.1016\/j.drugpo.2019.02.005.","journal-title":"Int J Drug Policy"},{"key":"711_CR66","unstructured":"Johnson D. Alberta government\u2019s new rules set SCS up to fail, advocates say. Filter Magazine. 2021. Available from: https:\/\/filtermag.org\/alberta-consumption-site-rules\/. Accessed 9 Dec 2021."},{"key":"711_CR67","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/09581590500372188","volume":"15","author":"G Roe","year":"2005","unstructured":"Roe G. Harm reduction as paradigm: Is better than bad good enough? The origins of harm reduction. Crit Public Health. 2005;15:243\u201350.","journal-title":"Crit Public Health"},{"key":"711_CR68","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/09581596.2011.611487","volume":"22","author":"CBR Smith","year":"2012","unstructured":"Smith CBR. Harm reduction as anarchist practice: a user\u2019s guide to capitalism and addiction in North America. Crit Public Health. 2012;22:209\u201321.","journal-title":"Crit Public Health"},{"key":"711_CR69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2006.11.006","volume":"18","author":"S Friedman","year":"2007","unstructured":"Friedman S, De Jong W, Rossi D, Touze G, Rockwell R, Des Jarlais D, Elovich R. Harm reduction theory: users\u2019 culture, micro-social Indigenous harm reduction, and the self-organization and outside-organizing of users\u2019 groups. Int J Drug Policy. 2007;18:107\u201317.","journal-title":"Int J Drug Policy"},{"key":"711_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/nvsm.198","volume":"8","author":"R Bennett","year":"2003","unstructured":"Bennett R. Factors underlying the inclination to donate to particular types of charity. Int J Nonprofit Volunt Sect Mark. 2003;8:12\u201329.","journal-title":"Int J Nonprofit Volunt Sect Mark"},{"key":"711_CR71","doi-asserted-by":"publisher","first-page":"e0251860","DOI":"10.1371\/journal.pone.0251860","volume":"16","author":"TC Wild","year":"2021","unstructured":"Wild TC, Koziel J, Anderson-Baron J, Asbridge M, Belle-Isle L, Dell C, Elliott R, Hathaway A, MacPherson D, McBride K, Pauly B, Strike C, Galovan A, Hyshka E. Public support for harm reduction: a population survey of Canadian adults. PLoS ONE. 2021;16:e0251860.","journal-title":"PLoS ONE"},{"key":"711_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/nvsm.7","author":"VB Eveland","year":"2007","unstructured":"Eveland VB, Crutchfield TN. Understanding why people do not give: strategic funding concerns for AIDS-related nonprofits. Int J Nonprofit Volunt Sect Mark. 2007. https:\/\/doi.org\/10.1002\/nvsm.7.","journal-title":"Int J Nonprofit Volunt Sect Mark"},{"key":"711_CR73","volume-title":"Do more than give: the six practices of donors who change the world","author":"LR Crutchfield","year":"2011","unstructured":"Crutchfield LR, Kania JV, Kramer MR. Do more than give: the six practices of donors who change the world. San Francisco: Jossey-Bass - A Wiley Imprint; 2011."},{"key":"711_CR74","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.chb.2009.10.015","volume":"26","author":"W Fan","year":"2010","unstructured":"Fan W, Yan Z. Factors affecting response rates of the web survey: a systematic review. Comput Hum Behav. 2010;26:132\u20139.","journal-title":"Comput Hum Behav"},{"key":"711_CR75","unstructured":"M+R. 2021 M+R benchmarks study. 2021. Available from: https:\/\/mrbenchmarks.com\/assets\/files\/2021_Benchmarks_Study.pdf."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00711-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:12:30Z","timestamp":1668640350000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00711-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00711-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"5 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and related protocols were approved by the University of Toronto HIV Research Ethics Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}